Early intensive treatment for PsA with csDMARDs or 6 months of TNFi is superior to standard step-up care, and better outcomes were maintained at 48 weeks in the TNFi group.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/early-intensive-therapy-best-psoriatic-arthritis-poor-2026a10007t0?src=rss
Author :
Publish date : 2026-03-13 11:02:00
Copyright for syndicated content belongs to the linked Source.
